Loading insider details...
Beta
Latest Form 4 (Aug 26, 2026): Grant/Award of 166 GOSS shares, $166.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 26, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 166 | $166.0K |
| Jun 4, 2026 | Kura Oncology, Inc. (KURA) | Grant/Award | 35,000 | n/a |
| Mar 20, 2026 | Gossamer Bio, Inc. (GOSS) | Disposition to Issuer | 1,680,000 | n/a |
| Jan 5, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 280,000 | n/a |
| Dec 10, 2025 | Kura Oncology, Inc. (KURA) | Exercise/Conversion | 10,000 | $31.2K |
| Oct 2, 2025 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 437,500 | n/a |
| Jun 6, 2025 | Kura Oncology, Inc. (KURA) | Grant/Award | 28,500 | n/a |
| Mar 24, 2025 | Kura Oncology, Inc. (KURA) | Exercise/Conversion | 22,682 | $143.4K |
| Mar 6, 2025 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 1,540,000 | n/a |
| Jun 24, 2024 | Gossamer Bio, Inc. (GOSS) | Purchase | 372,000 | $250.3K |